These observations are consistent with previous reports describing central nervous system involvement and multisystemic features in MFN2‐related disorders, including pyramidal signs, cognitive impairment, optic atrophy, and even cataracts [7, 8, 23]. The gene discussed is MFN2; the disease is optic atrophy.